Related Experiment Video
Updated: Jun 8, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
SHIP deficiency causes Crohn's disease-like ileitis
William G Kerr1, Mi-Young Park, Monique Maubert
1SUNY Upstate Medical University, 750 E. Adams Street, 2204 Weiskotten Hall, Syracuse, NY 13210, USA. kerrw@upstate.edu
The study reveals that SHIP deficiency causes inflammatory bowel disease (IBD) in mice, mimicking Crohn's disease. This immune dysfunction stems from altered T cell populations and increased neutrophils in the gut.
Area of Science:
- Immunology
- Gastroenterology
- Molecular Biology
Background:
- Inflammatory bowel disease (IBD) pathogenesis involves genetic factors affecting intestinal epithelial integrity and immune regulation.
- The SHIP protein is known to limit immunoregulatory cell numbers and function.
Purpose of the Study:
- To investigate the role of SHIP in maintaining immune tolerance within the gut mucosa.
- To determine if SHIP deficiency contributes to the development of IBD-like pathology.
Main Methods:
- Assessment of gastrointestinal pathology in SHIP-deficient and wild-type (WT) mice.
- Analysis of bone marrow chimeras involving WT and SHIP-deficient hematopoietic stem cells, splenocytes, T cells, and NK cells.
- Quantification of immune cell populations in the small intestine of SHIP-deficient and WT mice.
Main Results:
- SHIP-deficient mice exhibited segmental, transmural pyo-granulomatous ileitis, characteristic of Crohn's disease.
- Reconstitution of SHIP-deficient hosts with WT bone marrow corrected ileitis, while SHIP-deficient splenocytes transferred ileitis to WT hosts.
- SHIP deficiency led to a decrease in CD4 and CD8 T cells but a significant increase in neutrophils in the small intestine.
Conclusions:
- SHIP is crucial for intestinal immune function and its pathway warrants investigation in IBD patients.
- SHIP-deficient ileitis is proposed to result from impaired mucosal T cell immunity, leading to granulocyte-monocyte inflammation in the distal ileum.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

